WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP).
OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
2 min read Premium comments
#orthopediatricsTibia NailPediatric Nailing Platformcannulated rigid tibial nail
The PNP Tibia System was designed to bring a world-class, pediatric-focused nailing system to surgeons, enabling the use of rigid tibial nails in pediatric patients.
OrthoPediatrics’ introduction of the 7mm cannulated rigid tibial nail, the only product of its size, enables surgeons to treat patients who have previously been untreatable with adult systems. In fact, nearly 20% of all nails implanted by OrthoPediatrics have been the smallest 7mm size available. The implant is available in 7mm-12mm diameters.
Joe Hauser, President of Trauma & Deformity, stated, “The rapid adoption of this system demonstrates that OrthoPediatrics is filling a critical void in implant offerings to our core customer. The surgeon design team and our OrthoPediatrics engineers were meticulous in developing a system purpose-built for the needs of pediatric patients, and it is proving to be a valuable tool in treating over 1,000 kids with tibia fractures.”
The system includes small instruments to access the intramedullary canal, smaller overall nails, fixation options designed to avoid the physis, and instrumentation supporting both traditional and suprapatellar approaches.
PNP Tibia is currently available in five markets, with a European launch planned for 2027.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Taylor
Gilmartin Group
philip@gilmartinir.com
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
OrthoPediatrics' PNP Tibia System has achieved 1,000 implantations, demonstrating rapid market adoption by addressing a critical void in pediatric orthopedic offerings. The introduction of the unique 7mm cannulated rigid tibial nail provides a significant competitive advantage, enabling treatment for previously untreatable patients and capturing a substantial segment of the pediatric trauma market. This strategic focus reinforces OrthoPediatrics' leadership in pediatric orthopedics.
- The 7mm cannulated rigid tibial nail offers a unique market differentiator, expanding treatable pediatric patient populations.
- Rapid adoption and 1,000 implantations highlight successful market penetration and unmet need fulfillment in pediatric trauma.
PhD Lens: Clinical and outcomes impact
OrthoPediatrics' PNP Tibia System, featuring a unique 7mm cannulated rigid tibial nail, provides a specialized solution for pediatric tibia fractures. Its design incorporates small instruments, smaller nails (7-12mm), and physis-sparing fixation options, enabling treatment for patients previously untreatable with adult systems. This purpose-built system supports both traditional and suprapatellar approaches, addressing specific pediatric anatomical challenges.
- The system's design includes small instruments and physis-sparing fixation, crucial for pediatric anatomical considerations.
- The 7mm cannulated rigid tibial nail uniquely addresses smaller patient anatomies, expanding treatment options for pediatric trauma.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.